Skip to content

Effect of esketamine and erector spinae plane block on quality of recovery after thoracoscopic lung surgery: a randomized, controlled, factorial design trial

Effect of esketamine and erector spinae plane block on quality of recovery after thoracoscopic lung surgery: a randomized, controlled, factorial design trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063334
Enrollment
Unknown
Registered
2022-09-04
Start date
2022-09-05
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Quality of recovery after lung surgery

Interventions

Group1:Esketamine+ erector spinae plane block
Group2:Placebo+ erector spinae plane block
Group3:Esketamine+Intercostal nerve block
Group4:Placebo+Intercostal nerve block

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >= 18 years; 2. American Anesthesiologist Classification (ASA) I-III; 3. undergoing thoracoscopic pulmonary surgery under general anesthesia; 4. willing to participate in this study and provide written informed consent.

Exclusion criteria

Exclusion criteria: 1. Unplanned or emergency surgery; 2. Allergy to the drugs used in this study; 3. Severe cardiopulmonary disease (myocardial infarction, heart failure, type I or type II respiratory failure); 4. Severe cerebrovascular diseases (cerebral hemorrhage, stroke); 5. Severe liver and kidney diseases (Child-Pugh grade C, renal replacement therapy); 6. Severe neurological diseases (Parkinson's disease, Alzheimer's disease), use of antipsychotics, alcohol abuse, long-term use of opioids or other analgesics; 7. uncontrolled hypertension, increased intracranial pressure, high intraocular pressure (glaucoma), and penetrating ocular trauma; 8. Unable to understand postoperative recovery scale and pain rating scale; 9. BMI >= 35 kg/m2.

Design outcomes

Primary

MeasureTime frame
QoR-15 score;

Secondary

MeasureTime frame
QoR-15 score;VAS pain scores;fentanyl consumption;Use of rescue analgesics;hypotension;hypertension;bradycardia;tachycardia;use of vasopressors;use of atropine;PONV;use of antiemetics;adverse events (Respiratory depression, dizziness and mental side effects);severe complications (Pulmonary complications, cardiac complications, central nervous system complications, gastrointestinal complications, sepsis, postoperative bleeding, reoperation, death);Postoperative hospitalization days;

Countries

China

Contacts

Public ContactPeng Ke

The First Affiliated Hospital of Soochow University

pengke0422@163.com+86 15962155989

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026